Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Agreement and Plan of Merger

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Agreement and Plan of Merger

Entities:

Clinical Data, Inc.

Date:

2005

Size:

222KB total

Price:

$90

ID:

#1115084

 

 

► Plans ► Agreements ► Agreements & Plans of Merger
► Technology ► Scientific & Technical Instruments

 

 

Start of Preview


Execution Version

 

 

 

 

AGREEMENT AND PLAN OF MERGER

by and among

CLINICAL DATA, INC.,

IRIDES ACQUISITION CORP.

and

ICORIA, INC.

Dated as of September 19, 2005

 

 



 

 

TABLE OF CONTENTS

Page

ARTICLE I

THE MERGER

1

 

1.1

Effective Time of the Merger

1

 

1.2

Closing

2

 

1.3

Effects of the Merger

2

ARTICLE II

CONVERSION OF SECURITIES

2

 

2.1

Conversion of Capital Stock

2

 

2.2

Exchange of Certificates

5

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

8

 

3.1

Organization, Standing and Power; Subsidiaries

8

 

3.2

Capitalization

10

 

3.3

Authority; No Conflict; Required Filings and Consents

12

 

3.4

SEC Filings; Financial Statements; Information Provided

14

 

3.5

No Undisclosed Liabilities; Indebtedness

15

 

3.6

Absence of Certain Changes or Events

16

 

3.7

Taxes

16

 

3.8

Owned and Leased Real Properties

18

 

3.9

Intellectual Property

18

 

3.10

Agreements, Contracts and Commitments; Government Contracts

20

 

3.11

Litigation; Product Liability

21

 

3.12

Environmental Matters

22

 

3.13

Employee Benefit Plans

23

 

3.14

Compliance With Laws

25

 

3.15

Permits

25

 

3.16

Labor Matters

25

 

3.17

Insurance

26

 

3.18

Assets

26

 

3.19

Customers and Suppliers

26

 

3.20

Opinion of Financial Advisor

27

 

3.21

Section 203 of the DGCL Not Applicable

27

 

3.22

Brokers; Schedule of Fees and Expenses

27

 

 

- i -

 



 

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE PARENT AND THE
TRANSITORY SUBSIDIARY                                                                                                             27

 

4.1

Organization, Standing and Power

28

 

4.2

Capitalization

29

 

4.3

Authority; No Conflict; Required Filings and Consents

30

 

4.4

SEC Filings; Financial Statements; Information Provided

31

 

4.5

Absence of Certain Changes or Events

33

 

4.6

Intellectual Property

33

 

4.7

Agreements, Contracts and Commitments; Government Contacts

34

 

4.8

Litigation; Product Liability

34

 

4.9

Compliance With Laws

35

 

4.10

Operations of the Transitory Subsidiary

35

 

4.11

Brokers; Schedule of Fees and Expenses

35

ARTICLE V

CONDUCT OF BUSINESS

35

 

5.1

Covenants of the Company

35

 

5.2

Confidentiality

38

ARTICLE VI

ADDITIONAL AGREEMENTS

38

 

6.1

No Solicitation

38

 

6.2

Proxy Statement/Prospectus; Registration Statement

41

 

6.3

Nasdaq Quotation

42

 

6.4

Access to Information

42

 

6.5

Stockholders Meeting

42

 

6.6

Legal Conditions to the Merger

43

 

6.7

Public Disclosure

45

 

6.8

Section 368(a) Reorganization

45

 

6.9

Affiliate Legends

45

 

6.10

Nasdaq Stock Market Listing

45

 

6.11

Company Stock Plans, Company Warrants and Company Convertible Note                                     45

 

6.12

Indemnification

47

 

6.13

Notification of Certain Matters

48

 

6.14

Exemption from Liability Under Section 16(b)

49

 

6.15

Employee Benefits

49

 

 

- ii -

 



 

 

ARTICLE VII

CONDITIONS TO MERGER

50

 

7.1

Conditions to Each Party’s Obligation To Effect the Merger

50

 

7.2

Additional Conditions to Obligations of the Parent and the Transitory Subsidiary                         50

 

7.3

Additional Conditions to Obligations of the Company

52

ARTICLE VIII

TERMINATION AND AMENDMENT

53

 

8.1

Termination

53

 

8.2

Effect of Termination

54

 

8.3

Fees and Expenses

55

 

8.4

Amendment

56

 

8.5

Extension; Waiver

56

ARTICLE IX

MISCELLANEOUS

57

 

9.1

Nonsurvival of Representations and Warranties

57

 

9.2

Notices

57

 

9.3

Entire Agreement

58

 

9.4

No Third Party Beneficiaries

58

 

9.5

Assignment

58

 

9.6

Severability

58

 

9.7

Counterparts and Signature

59

 

9.8

Interpretation

59

 

9.9

Governing Law

59

 

9.10

Remedies

59

 

9.11

Submission to Jurisdiction

59

 

9.12

Waiver of Jury Trial

60

Schedule A

Parties to Company Stockholder Agreement

 

Schedule B

Material Contracts

 

Exhibit A

Form of Company Stockholder Agreement

Exhibit B

Form of By-laws of the Transitory Subsidiary

 

 

- iii -

 



 

 

TABLE OF DEFINED TERMS

 

Terms

Reference in
 Agreement 

Acquisition Proposal

Section 6.1(f)

Adjusted Convertible Note

Section 6.11(e)

Adjusted Warrant

Section 6.11(d)

Affiliate

Section 3.2(d)

Agreement

Preamble

Alternative Acquisition Agreement

Section 6.1(b)

Antitrust Laws

Section 6.6(b)

Antitrust Order

Section 6.6(b)

Business Day

Section 1.2

CERCLA

Section 3.12(f)

Certificate of Merger

Section 1.1

Certificates

Section 2.2(a)

Closing

Section 1.2

Closing Average Parent Stock Price

Section 2.1(c)

Closing Date

Section 1.2

Code

Preamble

Company

Preamble

Company Balance Sheet

Section 3.4(b)

Company Board

Section 3.3(a)

Company Common Stock

Section 2.1(b)

Company Convertible Note

Section 3.1(c)

Company Disclosure Schedule

ARTICLE III

Company Employee Plans

Section 3.13(a)

Company Insiders

Section 6.14(c)

Company Intellectual Property

Section 3.9(b)

Company Leases

Section 3.9(b)

Company Material Adverse Effect

Section 3.1(a)

Company Material Contracts

Section 3.10(a)

Company Permits

Section 3.15

Company Preferred Stock

Section 3.2(a)

Company SEC Reports

Section 3.4(a)

Company Stock Options

Section 3.2(c)

Company Stock Plans

Section 3.2(c)

Company Stockholder Agreements

Preamble

Company Stockholder Approval

Section 3.3(a)

Company Stockholders Meeting

Section 3.4(c)

Company Third Party Intellectual Property

Section 3.9(b)

Company Voting Proposal

Section 3.3(a)

Company Warrants

Section 3.2(c)

Confidential Business Information

Section 3.9(a)

 

 

- iv -

 



 

 

 

Confidentiality Agreement

Section 5.2

Costs

Section 6.12(a)

Continuing Employees

Section 6.15

Covered Parties

Section 6.12(a)

Dissenting Shares

Section 2.1(d)(i)

DGCL

Preamble

Effective Time

Section 1.1

Employee Benefit Plan

Section 3.13(a)

Environmental Law

Section 3.12(f)

ERISA Affiliate

Section 3.13(a)

ERISA

Section 3.13(a)

Exchange Agent

Section 2.2(a)

Exchange Fund

Section 2.2(a)

Exchange Act

Section 3.3(c)

Exchange Ratio

Section 2.1(c)

GAAP

Section 3.4(b)

Governmental Entity

Section 3.3(c)

Indebtedness

Section 3.5(b)

Insurance Policies

Section 3.17 below

Intellectual Property

Section 3.9(a)

Liens

Section 3.3(b)

Materials of Environmental Concern

Section 3.12(g)

McDermott

Section 7.2(c)

Merger

Preamble

Mintz

Section 7.2(c)

New Offer

Section 6.1(b)(iii)

Operating Plan

Section 5.1

Ordinary Course of Business

Section 3.2(d)

Outside Date